When will the data from the complete analysis be available? Who is doing it? Does B reduce the viral load in a clinical setting? Why is the Company encouraged by compassionate use. Is it simply because they have the requests or are there positive outcomes in this setting? Why the nebulous statements? There should be nothing to hide at this point.